VRAX - Virax Biolabs Group Limited Ordinary Shares
Virax Biolabs Group Limited Ordinary Shares Logo

VRAX - Virax Biolabs Group Limited Ordinary Shares

https://viraxbiolabs.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom.

52W High
$3.62
52W Low
$0.52
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.62
Valuation
As of 2024-09-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.42
EV/Revenue (<3 favorable)
27.27
P/S (TTM) (<3 favorable)
387.49
P/B (<3 favorable)
0.43
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
10.09%
Institutions (25–75% balanced)
6.06%
Shares Outstanding
4,342,000
Float
3,676,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2024-09-30 (Overview)
Revenue (TTM)
6,330
Gross Profit (TTM)
-53,067
EPS (TTM)
-1.62
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-2383.17%
ROE (TTM) (>15% strong)
-1.15%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.98
Momentum
Bearish momentum
Value
-0.0712
Previous
-0.0763
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025